Cho NH,Shaw JE,Karuranga S,Huang Y,da Rocha Fernandes JD,Ohlrogge AW .2018 .IDF diabetes atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract, 02 : 271-81.
Sloan G,Selvarajah D,Tesfaye S D .2021 .Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nat Rev Endocrinol, 10(7) : 400-20.
Shen Y,Guan S,Ge H,Xiong W,He L .2018 .E ects of palmatine on rats with comorbidity of diabetic neuropathic pain and depression. Brain Res Bull, 02 : 56-66.
Shillo P,Sloan G,Greig M,Hunt L,Selvarajah D,Elliott J .2019 .Painful and painless diabetic neuropathies: What is the di erence. Curr Diab Rep, 10(6) : 32.
Boulton AJ,Knight G,Drury J,Ward JD .1985 .The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population. Diabetes Care, 10(2) : 125-8.
Partanen J,Niskanen L,Lehtinen J,Mervaala E,Siitonen O,Uusitupa M. .1995 .Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med, 10(2) : 89-94.
Cole JB,Florez JC .2020 .Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol, 10(7) : 377-90.
Pandya NM,Dhalla NS,Santani DD .2006 .Angiogenesis-a new target for future therapy. Vascul Pharmacol, 01(5) : 265-74.
Zhao Y,Lei Y,Ning H,Zhang Y,Chen G,Wang C .2023 .PGF2± facilitates pathological retinal angiogenesis by modulating endothelial FOS-driven ELR+ CXC chemokine expression. EMBO Mol Med, 10(1) : .
Ropper AH,Gorson KC,Gooch CL,Weinberg DH,Pieczek A,Ware JH .2009 .Vascular endothelial growth factor gene transfers for diabetic polyneuropathy: A randomized, doubleblinded trial. Ann Neurol, 10(4) : 386-93.
Ved N,Da Vitoria Lobo ME,Bestall SM,BeazleyLong N,Ballmer-Hofer K .2018 .Diabetes-induced microvascular complications at the level of the spinal cord: A contributing factor in diabetic neuropathic pain. J Physiol, 10(16) : 3675-93.
Li Z,Wang Y,Liu C,Wang Z,Wang D,Liang X .2021 .Association between VEGF single nucleotide polymorphism and breast cancer in the Northern China Han population. Breast Cancer Res Treat, 10(1) : 149-56.
Han D,Qiao Z,Chen L,Qiu X,Fang D,Yang X .2017 .Interactions between the vascular endothelial growth factor gene polymorphism and life events in susceptibility to major depressive disorder in a Chinese populationJ. A ect Disord, 04 : 295-8.
Vodolazkaia A,Yesilyurt BT,Kyama CM,Bokor A,Schols D,Huskens D .2015 .Vascular endothelial growth factor pathway in endometriosis: Genetic variants and plasma biomarkers. Fertil Steril, 12(4) : 988-96.
ElHajj Chehadeh S,Sayed NS,Abdelsamad HS,Almahmeed W,Khandoker AH,Jelinek HF .2021 .Genetic variants and their associations to type 2 diabetes mellitus complications in the United Arab Emirates. Front Endocrinol (Lausanne), 751885 : 751885.
Renner W,Kotschan S,Obermayer-Pietsch C,Pilger B,E. B .2000 .A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res, 10(6) : 443-8.
Boltz A,Ruiß M,Jonas JB,Tao Y,Rensch F,Weger M .2012 .Role of vascular endothelial growth factor polymorphisms in the treatment success in patients with wet age-related macular degeneration. Ophthalmology, 02(8) : 1615-20.
Han SW,Kim GW,Seo JS,Kim SJ,Sa KH,Park JY .2004 .VEGF gene polymorphisms and susceptibility to rheumatoid arthritis. Rheumatology, 10(9) : 1173-7.
Tian H,Xu W,Wen L,Tang L,Zhang X,Song T .2022 .Association of PTPN22 SNP1858 (rs2476601) and gene SNP1123 (rs2488457) polymorphism with primary immune thrombocytopenia susceptibility: A meta-analysis of casecontrol studies and trial sequential analysis. Front Genet, 893669 : 893669.
Wells GA,Shea B,O'Connell D,Peterson J,Welch V,Losos M . .The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2021 [cited 2023]. , : .
Tian H,Xu W,Wen L,Tang L,Zhang X,Song T .2022 .Association of TLR3 gene 1377C/T (rs3775290) and TLR7 gene C/G (rs3853839) polymorphism with hand, foot, and mouth disease caused by human enterovirus 71 infection susceptibility and severity in the Chinese Han population: A meta-analysis of case-control studies. Medicine (Baltimore), 10(27) : .
El-Deeb S,ELSaeed G,Khodeer S,Dawood A,Omar T,Ibrahem R .2022 .Vascular endothelial growth factor with genetic variants rs3025020 and rs3025039 in diabetic microvascular complications. Menou a Med J, 139(1) : 21-35.
Yang-Xin D,Yuan-Fei Z,Xin-Huan Z Z .2011 .Association between the 936C/T polymorphism in the 3'-untranslated region of vascular endothelial growth factor gene and diabetic peripheral neuropathy in China. Zhong Hua Nei Fen Mi Dai Xie Za Zhi, 08(8) : 6699-53.
Barus J,Setyopranoto I,Sadewa AH,Wibowo S. .2018 .Vascular endothelial growth factor 936 C/T gene polymorphism in indonesian subjects with diabetic polyneuropathy. Open Access Maced J Med Sci, 399(10) : 1784-9.
Zhang X,Sun Z,Jiang H,Song X .2013 .Relationship between single nucleotide polymorphisms in the 3'-untranslated region of the vascular endothelial growth factor gene and susceptibility to diabetic peripheral neuropathy in China. Arch Med Sci, 39381(5) : 1028-34.
Kim HW,Ko GJ,Kang YS,Lee MH,Song HK,Kim HK .2009 .Role of the VEGF 936 C/T polymorphism in diabetic microvascular complications in type 2 diabetic patients. Nephrology, 01085(7) : 1797-8.
Ghisleni MM,Biolchi V,Jordon BC,Rempel C,Genro JP,Pozzobon A . .Association study of C936T polymorphism of the. , : .
Arredondo-Garcia VK,Cepeda-Nieto AC,Batallar-Gomez T,Salinas-Santander M,Zugasti-Cruz A,Ramirez-Calvillo L .2019 .Association of the vascular endothelial growth factor gene polymorphism +936 C/T with diabetic neuropathy in patients with type 2 diabetes mellitus. Arch Med Res, 07(4) : 181-6.
Feldman EL,Callaghan BC,Pop-Busui R,Zochodne DW,Wright DE,Bennett DL .2019 .Diabetic neuropathy. Nat Rev Dis Primers, 10(1) : 42.
Melincovici CS,Bosca AB,Susman S,Marginean M,Mihu C,Istrate M .2018 .Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. Rom J Morphol Embryol, 59(2) : 455-67.
Kakkar M,Behl T,Cruz CV-D-L T,Makeen HA,Albratty M,Alhazmi HA .2022 .Tridax procumbens ameliorates streptozotocininduced diabetic neuropathy in rats via modulating angiogenic, in ammatory, and oxidative path-ways. Evid Based Complement Alternat Med, 10 : .
Watson LP,Kang YH,Falk MC .1989 .Cytochemical properties of osteoblast cell membrane domains. J Histochem Cytochem, 10(8) : 1235-46.
Laakkonen JP,Lahteenvuo J,Jauhiainen S,Heikura T .2018 .Beyond endothelial cells: Vascular endothelial growth factors in heart, vascular anomalies and placenta. Vascul Pharmacol, 10 : .
Kim YJ,Chung WC,Jun KH,Chin HM .2019 .Genetic polymorphisms of vascular endothelial growth factor (VEGF) associated with gastric cancer recurrence after curative resection with adjuvant chemotherapy. BMC Cancer, 10(1) : 483.
Sharma PM,Gupta G,Vats A,Shapiro R .2006 .Phylogenetic analysis of polyomavirus BK sequences. J Virol, 10(18) : 06-79.
Scandurro AB,Beckman BS .1998 .Common proteins bind mRNAs encoding erythropoietin, tyrosine hydroxylase, and vascular endothelial growth factor. Biochem Biophys Res Commun, 8639(2) : 436-40.
Mermod N,Williams TJ,Tjian R .1988 .Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro. Nature, 10(6164) : 557-61.
Han L,Zhang L,Xing W,Zhuo R,Lin X,Hao Y .2014 .The associations between VEGF gene polymorphisms and diabetic retinopathy susceptibility: A meta-analysis of 11 case-control studies. J Diabetes Res, 10 : .
Zhou X,Yang N,Xu W,Li X,Spiliopoulou A,Theodoratou E. .2025 .Associations of genetic factors with vascular diabetes complications: An umbrella review. J Glob Health, 10 : 04081.
Chen CH,Ho CH,Kuan-Hua Huang S,Shen CH,Wu CC,Wang YH .2020 .Association between VEGF gene promoter polymorphisms and bladder cancer: An updated meta-analysis. Cytokine, 155112 : 155112.
Zhao J,Zhang LX,Wang YT,Li Y .2022 .Genetic polymorphisms and the risk of diabetic foot: A systematic review and meta-analyses. Int J Lower Extremity Wounds, 10(4) : 574-87.
Wei N,Chen Z,Xue Z,Zhu Y. .2015 .Polymorphism of VEGF gene in susceptibility to chronic immune-mediated in ammatory diseases: A meta-analysis. Rheumatol Int, 10(8) : 1351-60.
Deguchi T,Hashiguchi T,Horinouchi S,Uto T,Oku H,Kimura K .2009 .Serum VEGF increases in diabetic polyneuropathy, particularly in the neurologically active symptomatic stage. Diabet Med, 02680(3) : 5491-52.
Sondell M,Lundborg G,Kanje M. .1999 .Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci, 10(14) : 05731-40.
Tremolada G,Lattanzio R,Mazzolari G,Zerbini G. .2007 .The therapeutic potential of VEGF inhibition in diabetic microvascular complications. Am J Cardiovasc Drugs, 10(6) : 00129784-8.
Cameron NE,Cotter MA .2007 .Erectile dysfunction and diabetes mellitus: Mechanistic considerations from studies in experimental models. Current Diabetes Rev, 10(3) : 149-58.
Sondell M,Lundborg G,Kanje M. .1999 .Vascular endothelial growth factor stimulates Schwann cell invasion and neovascularization of acellular nerve grafts. Brain Res, 8993(99) : 02056-9.
Zhao Y,Zhu R,Wang D,Liu X .2019 .Genetics of diabetic neuropathy: Systematic review, meta-analysis and trial sequential analysis. Ann Clin Transl Neurol, 10(10) : 50892-2013.
Wu S,Han Y,Hu Q,Zhang X,Cui G .2017 .ects of common polymorphisms in the mthfr and ace genes on diabetic peripheral neuropathy progression: A meta-analysis. Mol Neurobiol, 10(4) : 2435-44.